{"id":"NCT00289848","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)","officialTitle":"A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of MK0431 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-03","primaryCompletion":"2007-03","completion":"2007-03","firstPosted":"2006-02-10","resultsPosted":"2010-04-02","lastUpdate":"2015-06-15"},"enrollment":530,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"sitagliptin phosphate","otherNames":["Januvia"]},{"type":"DRUG","name":"Comparator: placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"This is a clinical study to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (HbA1c) at Week 18","timeFrame":"Baseline and Week 18","effectByArm":[{"arm":"Sitagliptin 100 mg","deltaMin":-0.71,"sd":null},{"arm":"Placebo","deltaMin":0.31,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["19097665","33914296"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":352},"commonTop":[]}}